Cargando…
Transcription factor AP2 enhances malignancy of non-small cell lung cancer through upregulation of USP22 gene expression
BACKGROUND: Ubiquitin-specific protease 22 (USP22), a putative cancer stem cell marker, is frequently upregulated in cancers, and USP22 overexpression is associated with aggressive growth, metastasis, and therapy resistance in various human cancers including lung cancer. However, USP22 gene amplific...
Autores principales: | Sun, Ting, Zhang, Keqiang, Li, Wendong, Liu, Yunze, Pangeni, Rajendra P., Li, Aimin, Arvanitis, Leonidas, Raz, Dan J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9484186/ https://www.ncbi.nlm.nih.gov/pubmed/36123698 http://dx.doi.org/10.1186/s12964-022-00946-9 |
Ejemplares similares
-
Inhibition of USP7 upregulates USP22 and activates its downstream cancer-related signaling pathways in human cancer cells
por: Zhang, Keqiang, et al.
Publicado: (2023) -
Ubiquitin-specific protease 22 is critical to in vivo angiogenesis, growth and metastasis of non-small cell lung cancer
por: Zhang, Keqiang, et al.
Publicado: (2019) -
G9a regulates tumorigenicity and stemness through genome-wide DNA methylation reprogramming in non-small cell lung cancer
por: Pangeni, Rajendra P., et al.
Publicado: (2020) -
USP22 upregulates ZEB1-mediated VEGFA transcription in hepatocellular carcinoma
por: Zeng, Kai, et al.
Publicado: (2023) -
Cetuximab-Triptolide Conjugate Suppresses the Growth of EGFR-Overexpressing Lung Cancers through Targeting RNA Polymerase II
por: Zhang, Keqiang, et al.
Publicado: (2020)